| |
James O.
Schenk, Ph.D.
Professor
E-Mail:
geni@wsu.edu
Phone: (509)
335-7517
The work in our laboratory focuses on the development of micro
electro-analytical techniques for application to problems in neurobiology,
neuropharmacology, and biological psychiatry. The work involves the
construction and characterization of chemical micro-sensors for use in
monitoring the biogenic amine neurotransmitters, as well as neurobiologically
important inorganic ions. Our work is rather diverse in that we conduct basic
electrochemical studies with these small sensors, as well as explore their
usefulness for neuro-pharmacological and neurophysiological studies in vivo. |
|
|
|
| |
Problems of current
interest include miniaturization of chemical sensors to dimensions of less
than one micrometer, the development of electrochemical/neurobiological
metabolic models for interpreting chemical measurements in vivo, the
correlation of in vivo chemical signals with measures of brain cell electrical
activity, chemical measurements of subsecond components of neurotransmitter
release, the determination of the spatial and temporal constraints of
extracellular neurotransmitter influences at the level of the nerve cell, and
the chemistry and mechanism of action of antipsychotic drugs.
Biographical Information
James O. Schenk, Professor
of Chemistry, Pharmacy, Biochemistry and Biophysics, completed his
undergraduate work at Wofford College in Spartanburg, South Carolina, studied
clinical chemistry at Georgia State University, and received his Ph.D. in
analytical chemistry and neuroscience at the University of Kansas. He
subsequently spent one year as a National Institutes of Health postdoctoral
research training fellow and two years as a National Institute of Mental
Health postdoctoral research fellow in the Neuropsychopharmacology Research
Unit at Yale University School of Medicine. He remained at Yale for an
additional year as a postdoctoral associate before joining the Washington
State University faculty in the summer of 1986.
Selected Publications
Batchelor M. and
Schenk J. O. (1998) Protein kinase A may kinetically upregulate the
striatal transporter for dopamine. J. Neuroscience 18, 10304-10309.
Wayment H. K., Deutsch,
H., Schweri M. M., and Schenk J. O. (1999) Effects of methylphenidate
analogs on phenethylamine substrates for the striatal dopamine transporter:
potential as amphetamine antagonists? J. Neurochemistry 72, 1266-1274.
Earles C. and Schenk
J. O. (1999) Multisubstrate mechanism for the inward transport of dopamine
by the human dopamine transporter expressed in HEK cells and its inhibition by
cocaine. Synapse 33, 230-238.
Return to Faculty List
VCAPP Home
|
|